We are now well aware that inflammation plays an important role in the pathogenesis of
asthma. This awareness comes at a time when we question the etiology of increased …

Asthma is now regarded as an inflammatory disease, and inhaled glucocorticoids (iGCs) are
recommended earlier in the course of treatment of patients with this disorder. Although iGCs …

Inhaled corticosteroids are considered by many to be the anti-inflammatory therapy of choice
in adult asthma, given their remarkable efficacy and apparent safety. They are presently …

Inhaled corticosteroids are now recommended as first-line therapy for asthma. Although
these drugs clearly improve the symptoms of the disease and the associated physiologic …

Corticosteroids have numerous applications in treating inflammation and diseases of
immune function based on their significant anti-inflammatory and immunosuppressive …

The inhaled corticosteroids contain physicochemical differences that alter both
glucocorticoid receptor-binding characteristics and the pharmacokinetic variables of these …

Objective: To define the evidence for doses of inhaled corticosteroids in asthma and
describe this in clinically meaningful, evidence‐based terms. Data source: Cochrane …

Asthma is a chronic respiratory disease affecting approximately 300 million people
worldwide. 1 In the United States, an estimated 43.3 million people, including 9.3 million …

OBJECTIVE. To review the use of inhaled corticosteroids on asthma control in children by
using the new therapeutic paradigm outlined in the Expert Panel Report 3: Guidelines for the …

Inhaled corticosteroids are established as the mainstay of maintenance therapy for chronic
asthma. However, there remains some debate regarding the safety of long-term use of these …